# A Study to Investigate Safety, Tolerability and Pharmacokinetics of REM0045392 Compared With Placebo in Healthy Participants.

> **NCT07016464** · PHASE1 · TERMINATED · sponsor: **reMYND** · enrollment: 19 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** REM0045392
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07016464
- **Lead sponsor:** reMYND
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2025-03-20
- **Primary completion:** 2025-06-23
- **Final completion:** 2025-06-23
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** Sponsor decision
- **Last updated:** 2026-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07016464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07016464, "A Study to Investigate Safety, Tolerability and Pharmacokinetics of REM0045392 Compared With Placebo in Healthy Participants.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07016464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*